Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals

This publication has 14 references indexed in Scilit:

• Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses
  Clinical Immunology, 2005
• One NY-ESO-1-Derived Epitope That Promiscuously Binds to Multiple HLA-DR and HLA-DP4 Molecules and Stimulates Autologous CD4+ T Cells from Patients with NY-ESO-1-Expressing Melanoma
  The Journal of Immunology, 2005
• Using Modified Antigenic Sequences to Develop Cancer Vaccines: Are We Losing the Focus?
  PLoS Medicine, 2004
• Dominant B cell epitope from NY‐ESO‐1 recognized by sera from a wide spectrum of cancer patients: Implications as a potential biomarker
  International Journal of Cancer, 2004
• Survey of naturally occurring CD4 ⁺ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses
  Proceedings of the National Academy of Sciences, 2003
• NY-ESO-1 and CTp11 Expression May Correlate with Stage of Progression in Melanoma
  Journal of Surgical Research, 2001
• Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
  International Journal of Cancer, 2001
• CD4⁺T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production
  Proceedings of the National Academy of Sciences, 2001
• A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
  Proceedings of the National Academy of Sciences, 1997
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991